Interactions of muscarinic receptors with the heterotrimeric G proteins G(q) and G12: Transduction of proliferative signals

Journal of Neurochemistry

Volumn 68, Issue 2, 1997, Pages 525-533

  Burstein, E S ^a,b,d   Brauner Osborne H ^a,e   Spalding, T A ^a   Conklin, B R ^c   Brann, M R ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b ACADIA PHARMACEUTICALS INC   (United States)

^c GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

G proteins; G(q); G12; Muscarinic acetylcholine receptors

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MUSCARINIC RECEPTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; SIGNAL TRANSDUCTION; STOICHIOMETRY;

EID: 1842336902     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68020525.x     Document Type: Article

References (64)

1. Allen L. F., Lefkowitz R. J., Caron M. G., and Cotecchia S. (1991) G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the α1B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc. Natl. Acad. Sci. USA 88, 11354-11358.
2. Amatruda T. T. III, Dragas-Graonic S., Holmes R., and Perez H. D. (1995) Signal transduction by the formyl peptide receptor. Studies using chimeric receptors and site-directed mutagenesis define a novel domain for interaction with G-proteins. J. Biol. Chem. 270, 28010-28013.
3. Ammer H. and Schultz R. (1994) Retinoic acid-induced differentiation of human neuroblastoma SH-SY5Y cells is associated with changes in the abundance of G-proteins. J. Neurochem. 62, 1310-1318.
4. Brann M. R. and Cohen L. V. (1987) Diurnal expression of transducin mRNA and translocation of transducin in rods of rat retina. Science 235, 585-587.
5. Bräuner-Osborne H. and Brann M. R. (1996) Pharmacology of muscarinic acetylcholine receptor subtypes (m1-m5): high throughput assays in mammalian cells. Eur. J. Pharmacol. 295, 93-102.
6. q. FEBS Lett. 363, 261-263.
7. Burstein E. S., Spalding T. A., Hill-Eubanks D., and Brann M. R. (1995b) Structure-function of muscarinic receptor coupling to G proteins. J. Biol. Chem. 270, 3141-3146.
8. Burstein E. S., Spalding T. A., and Brann M. R. (1996a) Amino acid side chains that define muscarinic receptor/G-protein coupling. Studies of the third intracellular loop. J. Biol. Chem. 271, 2882-2885.
9. Burstein E. S., Spalding T. A., and Brann M. R. (1996b) Constitutive activation of chimeric m2/m5 muscarinic receptors and delineation of G-protein coupling selectivity domains. Biochem. Pharmacol. 51, 539-544.
10. 2A-adrenergic receptor to multiple G-proteins. J. Biol. Chem. 269, 5730-5734.
11. Chan A. M.-L., Fleming T. P., McGovern E. S., Chedid M., Miki T., and Aaronson S. A. (1993) Expression cDNA cloning of a transforming gene encoding the wild-type Gα12 gene product. Mol. Cell. Biol. 13, 762-768.
12. Chidiac P., Hebert T. E., Valiquette M., Dennis M., and Bouvier M. (1994) Inverse agonist activity of β-adrenergic antagonists. Mol. Pharmacol. 45, 490-499.
13. Clapham D. E. and Neer E. J. (1993) New roles for G-protein beta gamma-dimers in transmembrane signalling. Nature 365, 403-406.
14. Collins S., Caron M. G., and Lefkowitz R. J. (1992) From ligand binding to gene expression: insights into the regulation of G-protein-coupled receptors. Trends Biochem. Sci. 17, 37-39.
15. qα. Mutational activation and coupling to receptors and phospholipase C. J. Biol. Chem. 267, 31-34.
16. iα. Nature 363, 274-276.
17. Coso O. A., Chiariello M., Kalinec G., Kyriakis J. M., Woodgett J and Gutkind J. S. (1995) Transforming G protein-coupled receptors potently activate JNK (SAPK). Evidence for a divergence from the tyrosine kinase signaling pathway. J. Biol. Chem. 270, 5620-5624.
18. Crespo P., Xu N., Simonds W. F., and Gutkind J. S. (1994) Rasdependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits. Nature 369, 418-420.
19. Eason M. C., Kurose H., Holt B. D., Raymond J. R., and Liggett S. B. (1992) Simultaneous coupling of α2-adrenergic receptors to two G-proteins with opposing effects. J. Biol. Chem. 267, 15795-15801.
20. + channel. J. Biol. Chem. 269, 30707-30712.
21. Gardner A. M., Vaillancourt R. R., and Johnson G. L. (1993) Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase by G protein and tyrosine kinase oncoproteins. J. Biol. Chem. 268, 17896-17901.
22. Gutkind J. S., Novotny E. A., Brann M. R., and Robbins K. C. (1991) Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc. Natl. Acad. Sci. USA 88, 4703-4707.
23. Hadcock J. R., Ros M., Watkins D. C., and Malbon C. C. (1990) Cross-regulation between G-protein mediated pathways: stimulation of adenylyl cyclase increases expression of the inhibitory G-protein Gi2. J. Biol. Chem. 265, 14784-14790.
24. Haraguchi K. and Rodbell M. (1990) Isoproterenol stimulates shift of G proteins from plasma membrane to pinocytotic vesicles in rat adipocytes: a possible means of signal dissemination. Proc. Natl. Acad. Sci. USA 87, 1208-1212.
25. i2 protein have opposite effects on proliferation of NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 88, 10455-10459.
26. Hilf G. and Jakobs K. H. (1992) Agonist-independent inhibition of G protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes. Eur. J. Pharmacol. 225, 245-252.
27. Hill-Eubanks D., Burstein E. S., Spalding T. A., Bräuner-Osborne H., and Brann M. R. (1996) Structure of a G-protein-coupling domain of a muscarinic receptor predicted by random saturation mutagenesis. J. Biol. Chem. 271, 3058-3065.
28. Hulme E. C., Birdsall N. J. M., and Buckley N. J. (1990) Muscarinic receptor subtypes. Annu. Rev. Pharmacol Toxicol. 30, 633-673.
29. Jakubik J., Bacakova L., El-Fakahany E. E., and Tuček S. (1995) Constitutive activity of the M1-M4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists. FEBS Lett. 377, 275-279.
30. Jiang H., Wu D., and Simon M. I. (1992) The transforming activity of activated Gα12. FEBS Lett. 330, 319-322.
31. Johnson G. L., Gardner A. M., Lange-Carter C., Qian N. X., Russell M., and Winitz S. (1994) How does the G protein. Gi2, transduce mitogenic signals? J. Cell. Biochem. 54, 415-422.
32. Jones S. V. P. Levey A. I., Weiner D. M., Ellis J., Novotmy E., Yu S.-H., Dorje F., Wess J., and Brann M. R. (1992) Muscarinic acetylcholine receptors, in Molecular Biology of G-Protein-Coupled Receptors (Brann M. R., ed), pp. 170-197. Birkhauser, Boston.
33. Julius D., Livelli T. J., Jessell T. M., and Axel R. (1989) Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science 244, 1057-1062.
34. q protein induces malignant transformation in NIH 3T3 cells. Mol. Cell Biol. 12, 4687-4693.
35. i2. J. Cell Biol. 121, 91-99.
36. α16 contribute to the specificity of activation by the C5a receptor. Mol. Pharmacol. 47, 218-223.
37. Leff P. (1995) The two state model of receptor activation. Trends Pharmacol. Sci. 16, 89-97.
38. Levis M. J. and Bourne H. R. (1992) Activation of the α subunit of Gs in intact cells alters its abundance, rate of degradation and membrane avidity. J. Cell Biol. 119, 1297-1307.
39. Liang B. T., Hellmich M. R., Neer E. J., and Galper J. B. (1986) Development of muscarinic cholinergic inhibition of adenylate cyclase in embryonic chick heart. J. Biol. Chem. 261, 9011-9021.
40. Lim K. and Chae C.-B. (1989) A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase. Biotechniques 7, 576-579.
41. Lyons J., Landis C. A., Harsh G., Vallar L., Grünewald K., Feichtinger H., Duh Q.-Y., Clark O. H., Kawasaki E., Bourne H. R., and McCormick F. (1990) Two G protein oncogenes in human endocrine tumors. Science 249, 655-659.
42. Messier T. L., Dorman C. M., Bräuner-Osborne H., Eubanks D., and Brann M. R. (1995) High throughput assays of cloned adrenergic, muscarinic, neurokinin, and neurotrophin receptors in living mammalian cells. Pharmacol. Toxicol. 76, 308-311.
43. Milligan G. (1993) Agonist regulation of cellular G-protein levels and distribution: mechanisms and functional implications. Trends Pharmacol. Sci. 14, 413-418.
44. 11α following activation of the human M1 muscarinic acetylcholine receptor expressed in CHO cells. Biochem. J. 293, 495-499.
45. Pace A. M., Wong Y. H., and Bourne H. R. (1991) A mutant alpha subunit of Gi2 induces neoplastic transformation of Rat-1 cells. Proc. Natl. Acad. Sci. USA 88, 7031-7035.
46. Pelech S. L. and Sanghera J. S. (1992) MAP kinases: charting the regulatory pathways. Science 257, 1355-1356.
47. Perez D. M., Hwa J., Gaivin R., Mathur M., Brown F., and Graham R. M. (1996) Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. Mol. Pharmacol. 49, 112-122.
48. Rens-Domiano S. and Hamm H. E. (1995) Structural and functional relationships of heterotrimeric G-proteins. FASEB J. 9, 1059-1066.
49. Robb S., Cheek T. R., Hannan F. L., Hall L. M., Midgley J. M., and Evans P. D. (1994) Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems. EMBO J. 13, 1325-1330.
50. Rubenstein R. C., Linder M. E., and Ross E. M. (1991) Selectivity of the β-adrenergic receptor among Gs, Gi's and Go. Assay using recombinant α subunits in reconstituted phospholipid vesicles. Biochemistry 30, 10769-10777.
51. 2-adrenergic receptor. J. Biol. Chem. 268, 4625-4636.
52. Schlessinger J. (1993) How receptor tyrosine kinases activate Ras. Trends Biochem. Sci. 18, 273-275.
53. Simon M. I., Strathmann M. P., and Gautam N. (1991) Diversity of G proteins in signal transduction. Science 252, 802-808.
54. Soejima M. and Noma A. (1984) Mode of regulation of the ACh-sensitive K-channel by the muscarinic receptor in rabbit atrial cells. Pflugers Arch. 400, 424-431.
55. Spengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., and Seeburg P. H. (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature 365, 170-175.
56. Strathmann M. and Simon M. I. (1990) G protein diversity: a distinct class of alpha subunits is present in vertebrates and invertebrates. Proc. Natl. Acad. Sci. USA 87, 9113-9117.
57. Strathmann M. P. and Simon M. I. (1991) Gα12 and Gα13 subunits define a fourth class of G protein α subunits. Proc. Natl. Acad. Sci. USA 88, 5582-5586.
58. Vara Prasad M. V. V. S., Dermott J. M., Heasley L. E., Johnson G. L., and Dhanasekaran N. (1995) Activation of Jun kinase/ stress-activated protein kinase by GTPase-deficient mutants of G12 and G13. J. Biol. Chem. 270, 18655-18659.
59. Voyno-Yasenetskaya T. A., Pace A. M., and Bourne H. R. (1994) Mutant alpha subunits of G12 and G13 proteins induce neoplastic transformation of Rat-1 fibroblasts. Oncogene 9, 2559-2565.
60. Voyno-Yasenetskaya T. A., Faure M. P., Ahn N. G., and Bourne H. R. (1996) Gα12 and Gα13 regulate extracellular signal-regulated kinase and c-Jun kinase pathways by different mechanisms in COS-7 cells. J. Biol. Chem. 271, 21081-21087.
61. Wigler M., Silverstein S., Lee L.-S., Pellicer A., Cheng Y.-C., and Axel R. (1977) Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell 11, 223-232.
62. 1C adrenergic receptors. J. Biol. Chem. 270, 17196-17203.
63. Wu D., Katz A., Lee C. H., and Simon M. I. (1992) Activation of phospholipase C by alpha 1-adrenergic receptors is mediated by the alpha subunits of Gq family. J. Biol. Chem. 267, 25798-25802.
64. 12 potentiates the eicosanoid pathway and is highly oncogenic in NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 90, 6741-6745.